Have you ever been prescribed a drug for a condition or disease not specifically approved by regulatory authorities? This practice, known as “off-label” use, is common in healthcare worldwide, including in both the EU and US markets.

How Does Drug Approval Work?

Before a drug is approved, pharmaceutical companies must submit extensive clinical data demonstrating that the drug is both safe and effective for specific uses. In this context, “safe” means that the benefits of using the drug for a particular condition outweigh its potential risks. Approval signifies that regulatory authorities, such as the European Medicines Agency (EMA) or the FDA (Food and Drug Administration), have thoroughly evaluated the drug’s benefits and risks, supported by strong scientific data, and provided healthcare providers with detailed labelling on how to use the drug safely and effectively.

The Role of Woodley BioReg

At Woodley BioReg, we understand the complexities and nuances of off-label use of approved drugs. Our expertise in regulatory compliance ensures that healthcare providers and pharmaceutical companies navigate this practice with the highest standards of safety and efficacy. While off-label prescribing can offer significant benefits, it also carries risks that must be carefully managed. We provide comprehensive support in evaluating the legal and ethical considerations, ensuring that all off-label use is backed by solid scientific evidence and complies with relevant regulations.

What Does Off-Label Mean?

Off-label use refers to prescribing a medication for a different purpose than those formally approved by regulatory authorities and included in the drug’s labelling. While authorities like the EMA or FDA approve medications for specific uses, they do not regulate how doctors practice medicine or what drugs they prescribe for particular illnesses. This means that once a drug is approved, healthcare providers are free to prescribe it for any condition they believe is medically appropriate, even if that condition is not listed on the approved label.

Doctors might prescribe medications off-label for various reasons, such as when a particular use is well-known, has been done for many years without concerns, or when there is a lack of safe or effective alternatives. Off-label use can often provide valuable treatment options, especially when approved therapies have not been successful.

Is Off-Label Prescribing Legal?

Yes, off-label prescribing is entirely legal and is a common practice among physicians. It is also acceptable to study and publish research results on off-label uses of drugs without requiring specific approval for those uses. However, while it is legal for doctors to prescribe drugs off-label, drug manufacturers are prohibited from promoting such uses. This restriction is in place to prevent conflicts of interest, ensuring that off-label uses are based on sound medical judgment and evidence rather than commercial interests. Until a drug manufacturer conducts the necessary studies and gains regulatory approval for a new use, that use remains officially off-label.

Is Off-Label Use of Approved Drugs Safe?

The safety of off-label prescribing can vary. Many off-label uses are considered safe, especially when doctors are well-acquainted with the drug, including its dosing, safety profile, and data from post-approval clinical trials related to the off-label use. Some off-label practices have been in use for years or even decades without significant safety concerns.

However, research has shown that a significant portion of off-label prescriptions may lack strong scientific evidence. For instance, a study published in JAMA Internal Medicine found that about 1 in 10 prescriptions are written for off-label use, and of those, 80% lacked strong scientific evidence. The study also indicated that when a drug is prescribed off-label without solid evidence, there is a higher risk of side effects. Specifically, patients prescribed off-label drugs without robust evidence were 54% more likely to experience an issue that led to discontinuation of the medication, such as side effects, drug interactions, or allergic reactions.

It’s crucial for patients and healthcare providers to carefully weigh the risks and benefits before deciding on off-label use.

Why Would a Doctor Prescribe Off-Label Use of Approved Drugs?

There are several reasons why a healthcare provider might consider off-label use:

Lack of Approved Alternatives: There might not be an approved drug available for your specific condition.

Ineffective Approved Treatments: You may have tried all approved therapies without success, leading your provider to explore off-label options.

Established Practice: The off-label use might be well-documented in medical literature and commonly practiced without any significant safety concerns.

While off-label use can be beneficial, it’s important to understand that regulatory authorities have not officially determined the drug to be safe or effective for the unapproved use. This means the decision to use a drug off-label is based on the provider’s judgment, available scientific evidence, and your specific medical needs.

At Woodley BioReg, we are committed to helping our clients navigate the complexities of off-label drug use, ensuring that all decisions are informed by the latest scientific evidence and regulatory requirements, whether in the EU, US, or global markets.

 

Discover more insights from Woodley BioReg and how we can support you

Back to News + Insights